Fortis Healthcare Ltd

Fortis Health. | 532843

Market Closed

₹915.00

+₹8.07 (+0.89%)

As on 01/09/26, 11:42 PM

Market Cap68,467.15 CR

Current Price₹915

High / Low₹1,104.3 / 766.8

PE Ratio57.58

Book Value₹131.07

Dividend Yield0.13%

ROCE13.36%

ROE2.13%

Face Value₹2.00

Current Vol.16,05,569

Average Vol.---

ISININE061F01013

PB Ratio6.06

Debt to Equity0.32

Net Profit Margin11.2

Operating Margin22.41

FORTIS - Share Price Chart

+₹0.00 (+0.00%)6M

Stock Performance

₹906.9₹911.6

₹915

Previous CloseToday's Open

₹766.8₹1,104.3

₹915

52W Low52W High

₹911.6Today's Open

₹906.9Previous Close

16,05,569Volume

₹766.852W Low

₹1,104.352W High

Ratios

No data available

About Company

Fortis Healthcare Limited (FHL) is one of the largest healthcare services providers in India with 36 hospitals, ~6,100 operational beds and 400+ diagnostics centres as of 31 March, 2026
The Company offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services to patients in areas such as Cardiac Care, Orthopedics, Neurosciences, Oncology, renal care, Gastroenterology and Mother and Child care
They are delivering quality healthcare services to patients in modern facilities using advanced technology
SRL Limited, a subsidiary of FHL is primarily involved in providing diagnostics services and is amongst the leading diagnostics chains in India with a significant market share in the organized diagnostics segment
FHL currently owns a fully diluted stake of 56
Fortis Healthcare Limited was incorporated on February 28, 1996
The Company commenced their commercial operation by setting up the Fortis Heart Institute and Multi-Speciality Hospital at Mohali in the year 2001
In December 2002, International Hospital Limited became a board controlled subsidiary of the company
In August 2003, Fortis Hospital in Amristar was inaugurated
In October 2003, the company executed an agreement with Seth Jessa Ram and Bros Charitable Hospital Trust for the operation and management of Jessa Ram Hospital, New Delhi and Fortis Hospital in Noida was commissioned in August 2004

Ethics: Fortis Healthcare Ltd is flagged for

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

Adequate

The company demonstrates adequate ESG practices with room for improvement.

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI43.02

SMA 20920.71

SMA 50943.49

SMA 100942.49

SMA 200914.01

SMA 10915.70

MACD_12_26_Days-8.10

EMA10Day917.05

EMA20Day922.65

EMA50Day934.03

MACD_12_26_9_Days0.90

EMA100Day932.45

EMA200Day913.40

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth17.20%

ROE11.31%

EBITDA Margin22.41%

All figures in ₹ Crores

Indicators	2026	2025	2024	2023	2022
Revenue	9,127.84	7,782.75	6,892.92	6,297.63	5,717.61
Interest	314.47	184.41	130.95	129.09	146.85
Expenses	7,042.86	6,194.80	5,625.29	5,196.29	4,648.65
Financing Profit	2,151.99	1,666.41	1,315.39	1,184.90	1,120.44
Financing Margin %	24%	21%	19%	19%	20%
Other Income	67.01	78.46	47.76	83.56	51.48
Depreciation	449.43	385.61	342.50	315.74	300.84
Profit before tax	1,365.85	1,007.05	857.97	813.68	987.79
Tax %	22%	20%	25%	22%	20%
Net Profit	1,064.19	809.38	645.22	632.98	789.95
EPS in Rs	13.80	10.26	7.93	7.80	7.35

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

Deal	Date	Type	Quantity	Price	Traded %
GOLDMAN SACHS BANK EUROPE SE - ODI	07 Oct ‘25	Purchase	2,19,013	₹1,042	7.06%
GOLDMAN SACHS (SINGAPORE) PTE - ODI	07 Oct ‘25	Sell	2,19,013	₹1,042	7.06%
GOLDMAN SACHS BANK EUROPE SE - ODI	18 Sept ‘25	Purchase	3,36,879	₹963.5	34.73%
GOLDMAN SACHS (SINGAPORE) PTE - ODI	18 Sept ‘25	Sell	3,36,879	₹963.5	34.73%
GOLDMAN SACHS BANK EUROPE SE - ODI	17 Sept ‘25	Purchase	3,83,961	₹966.65	24.05%
GOLDMAN SACHS (SINGAPORE) PTE - ODI	17 Sept ‘25	Sell	3,83,961	₹966.65	24.05%
UBS AG	23 Jan ‘25	Purchase	25,75,203	₹638.65	253.31%
UBS PRINCIPAL CAPITAL ASIA LIMITED	23 Jan ‘25	Sell	25,75,203	₹638.65	253.31%
ISHARES CORE MSCI EMERGING MARKETS ETF	14 Nov ‘22	Purchase	5,93,464	₹282.25	5.24%
ISHARES CORE EMERGING MARKETS MAURITIUS CO	14 Nov ‘22	Sell	5,93,464	₹282.25	5.24%

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

11 Aug 2026

AGM

17 Jul 2026

24 Jul 2026

Final Dividend (₹1)

Recommended final dividend of ? 1/- (Rupee One) per equity share (10% of face value of ?10 /- each), for the financial year 2025-26. Company has fix the Record date for payment of Dividend (As Per BSE Announcement Dated on:17.07.2026).

22 May 2026

11 Aug 2025

AGM

11 Jul 2025

25 Jul 2025

Final Dividend (₹1)

Recommended final dividend of 1 per equity share (10% of face value of 10 /- each),for the financial year 2024-25, subject to approval of the members of the Company.

20 May 2025

02 Aug 2024

AGM

02 Jul 2024

24 Jul 2024

Final Dividend (₹1)

Dividend: Considered and recommended final dividend of ?1 per equity share (10% of face value of ?10 /- each), for the financial year 2023-24, subject to approval of the members of the Company, which shall be paid/ dispatched within 30 days from the conclusion of the ensuing Annual General Meeting, if approved.

23 May 2024

01 Aug 2023

AGM

30 Jun 2023

20 Jul 2023

Final Dividend (₹1)

This is to inform you that the Board of Directors of the Company at its meeting held today i.e. May 23, 2023, inter-alia, has: a)Considered and approved the standalone and consolidated audited financial results of the Company for the quarter and financial year ended on March 31, 2023. M/s B S R and Co. LLP, the Statutory Auditors of the Company have issued an Audit Report with unmodified opinion. b) Considered and recommended a final dividend of ? 1 /- per equity share (10% of face value of ? 10 /- each), for the financial year 2022-23, subject to approval of the members of the Company, which shall be paid/ dispatched within 30 days from the conclusion of the ensuing Annual General Meeting. The Company has fixed July 20, 2023 as Record Date for the purpose of payment of final dividend, subject to the approval of the shareholders in the Annual General Meeting scheduled to be held on August 1, 2023. Detailed disclosure in this regard is enclosed herewith. (As Per BSE Announcement dated on 30.06.2023)

24 May 2023

01 Aug 2022

AGM

21 Jun 2022

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
911	68,769	64	7	45	0	11.20%
8,763	1,25,998	60	13	42	1	7.94%
747	98,259	105	6	59	1	8.87%
1,007	98,009	65	9	50	0	17.23%
758	66,090	170	14	100	0	7.26%
1,938	39,605	46	9	29	1	10.21%
1,457	39,163	68	10	48	0	12.56%
1,904	31,950	57	13	44	0	18.45%
759	31,878	153	9	59	2	6.20%
1,755	17,790	56	6	40	0	14.05%

Showing 10 of 70 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in just 5 minutes*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

EPLEPL Ltd
₹240.35-21.71 (-8.28%)

Group Stocks

Adani Stocks

Tata Group Stocks

Frequently Asked Questions

What is Share Price of Fortis Healthcare Ltd?

The current share price of Fortis Healthcare Ltd (Fortis Health.) is ₹915.00. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Fortis Healthcare Ltd?

The Price-to-Earnings (P/E) ratio of Fortis Healthcare Ltd is 915.00. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Fortis Healthcare Ltd?

Fortis Healthcare Ltd has a 52-week high of ₹1104.30 and a 52-week low of ₹766.80. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Fortis Healthcare Ltd?

Fortis Healthcare Ltd offers a dividend yield of 0.11%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Fortis Healthcare Ltd?

The Earnings Per Share (EPS) of Fortis Healthcare Ltd is ₹14.13. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Fortis Healthcare Ltd?

Fortis Healthcare Ltd has a Return on Equity (ROE) of 2.13%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video